Treatment for Type-2-Diabetes News: Fixed Combination of DPP-4 and SGLT-2 Inhibitors

被引：0
|
作者：
不详
机构：
来源：
DIABETES STOFFWECHSEL UND HERZ | 2018年 / 27卷 / 03期
关键词：
TYPE-2; DIABETES-MELLITUS; MILLION PEOPLE; SITAGLIPTIN; THERAPY; RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [41] THE PLACEMENT OF DPP-4 INHIBITORS IN CLINICAL PRACTICE RECOMMENDATIONS FOR THE TREATMENT OF TYPE 2 DIABETES
    Davidson, Jaime A.
    ENDOCRINE PRACTICE, 2013, 19 (06) : 1050 - 1061
  • [42] DPP-4 inhibitors for the treatment of type 2 diabetes: a methodology overview of systematic reviews
    Ling, Juan
    Ge, Long
    Zhang, Ding-hua
    Wang, Yong-feng
    Xie, Zhuo-lin
    Tian, Jin-hui
    Xiao, Xiao-hui
    Yang, Ke-hu
    ACTA DIABETOLOGICA, 2019, 56 (01) : 7 - 27
  • [43] Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus
    Sesti, Giorgio
    Avogaro, Angelo
    Belcastro, Sara
    Bonora, Benedetta Maria
    Croci, Marina
    Daniele, Giuseppe
    Dauriz, Marco
    Dotta, Francesco
    Formichi, Caterina
    Frontoni, Simona
    Invitti, Cecilia
    Orsi, Emanuela
    Picconi, Fabiana
    Resi, Veronica
    Bonora, Enzo
    Purrello, Francesco
    ACTA DIABETOLOGICA, 2019, 56 (06) : 605 - 617
  • [44] Association Between SGLT2 Inhibitors vs DPP-4 Inhibitors and Risk of Pneumonia Among Patients With Type 2 Diabetes
    Au, Philip C. M.
    Tan, Kathryn C. B.
    Cheung, Bernard M. Y.
    Wong, Ian C. K.
    Wong, Ying
    Cheung, Ching-Lung
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (04): : E1719 - E1726
  • [45] Effects of DPP-4 Inhibitors on Cardiovascular System in Type 2 Diabetes
    Ohno, Yasuhiro
    Tanaka, Yoichi
    Fujimoto, Mika
    Maruyama, Yasunori
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [46] DPP-4 inhibitors and their potential role in the management of type 2 diabetes
    Barnett, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (11) : 1454 - 1470
  • [47] The role of SGLT-2 inhibitors in managing type 2 diabetes
    Tsushima, Yumiko
    Lansang, M. Cecilia
    Makin, Vinni
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (01) : 47 - 58
  • [48] SGLT-2 inhibitors for people with type 2 diabetes Reply
    Zelniker, Thomas A.
    Wiviott, Stephen D.
    Raz, Itamar
    Sabatine, Marc S.
    LANCET, 2019, 394 (10198): : 560 - 561
  • [49] Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
    Gallwitz, Baptist
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 1 - 9
  • [50] Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
    Ahren, Bo
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 31 - 41
12345